Funded Startups in Cambridge
The largest disclosed round in this Cambridge-focused set is Suno’s $400M Series D on 2026-06-03, which dwarfs the next-largest disclosed amounts (e.g., Ci…
The largest disclosed round in this Cambridge-focused set is Suno’s $400M Series D on 2026-06-03, which dwarfs the next-largest disclosed amounts (e.g., City Therapeutics at $100M on 2026-06-08 and Flare Therapeutics at $85M on 2026-06-30). In size terms, most disclosed rounds sit below $100M (such as Hyperlight’s $80M on 2026-06-18 and Parabilis Medicines’ $75M on 2026-06-11), while a small group ranges from ~$120M to ~$300M (e.g., CREATE Medicines $122M on 2026-05-14; CellCentric $220M on 2026-05-06; Aura Biosciences $299M on 2026-05-04).
Date-wise, the “Cambridge” results cluster tightly from 2026-04-16 through 2026-06-30 (the most recent row is Flare Therapeutics on 2026-06-30). Geographically, Cambridge, Massachusetts dominates, but Cambridge entries also appear as Cambridge (Cambridgeshire, UK) and Cambridge, Ontario (e.g., Nightmare Games on 2026-05-06 at $220K). Sector-wise, biotechnology and AI both appear repeatedly (biotechnology in at least 20 entries; AI in at least 8), and stage labels are frequently missing: five entries show “undisclosed” amounts and many are marked “Series Unknown.”
Most recent rounds
50 of 581531 more funded startups
This page shows the 50 most recent rounds (back to Apr 2026). The full 581-company history for this listing is available on a paid plan.
Unlock all 581 companies in this listing — full funding history, investors, and founders.
Related listings
Frequently asked
What are the size outliers, and how do they compare to the rest of the disclosed rounds?
Suno’s $400M disclosed Series D (2026-06-03) is the clear high end, far above the other disclosed concentrations—several large rounds are in the $120M–$300M bracket (e.g., CellCentric $220M on 2026-05-06; Aura Biosciences $299M on 2026-05-04; Relay Therapeutics $275M on 2026-05-20). At the low end, the smallest disclosed amount is $30K, appearing across multiple Cambridge-region entries (e.g., Faraday Predictive on 2026-04-17; MorphoAI on 2026-04-17; Sesame Sustainability on 2026-04-17).
Are there temporal clusters in the Cambridge deals listed here?
Yes. All 50 rows fall between 2026-04-16 and 2026-06-30, and the densest run is late May through June, including multiple same-week closings like 2026-06-03 (Flok Health $13M; Marble $30M; Suno $400M) and 2026-05-20 (Relay Therapeutics $275M; Tevard Biosciences undisclosed).
Does the city/state mix show a dominant geography or meaningful splits?
Cambridge, Massachusetts accounts for most disclosed rounds (e.g., Flare Therapeutics $85M on 2026-06-30; Hyperlight $80M on 2026-06-18; Iterative Health $77M on 2026-04-30), while Cambridge, Cambridgeshire (UK) and Cambridge, Ontario are smaller but still present (e.g., Raspberry Pi $67M on 2026-04-24 in the UK; Nightmare Games $220K on 2026-05-06 in Ontario).
How concentrated is biotechnology vs. AI in this list, and do they align with larger disclosed rounds?
Biotechnology appears in at least 20 entries (e.g., Flare Therapeutics $85M on 2026-06-30; Dyne Therapeutics $200M on 2026-06-17; Editas Medicine $125M on 2026-05-26), while AI appears in at least 8 entries (e.g., Suno $400M on 2026-06-03; Iterative Health $77M on 2026-04-30; Marble $30M on 2026-06-03). The largest disclosed rounds include both categories—most notably Suno’s AI $400M, alongside biotech-heavy large checks like Aura Biosciences $299M (2026-05-04).
What stage labeling patterns stand out, especially around “Series Unknown” and undisclosed amounts?
Stage is frequently missing: multiple companies are listed as “Series Unknown” (e.g., Wyld Networks on 2026-06-30 at $510K; Decoy Therapeutics on 2026-06-26 at $4M; Undundo on 2026-06-16 at $37M). Separately, five rows carry “undisclosed” amounts (e.g., Shuimu BioSciences on 2026-06-11; Harness Therapeutics on 2026-06-09; Tevard Biosciences on 2026-05-20), which limits size-based comparisons for those specific rounds.
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.